![]() European Medical Solutions European Medical Solutions (formerly known as ASIT Biotech) is a clinical-stage biopharmaceutical company that focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies. | ![]() Adocia Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. | ![]() Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. | AiCuris AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents. | |
Founding Date | Founding Date 1997 | Founding Date 2005 | Founding Date 2007 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Liège, BE HQ Sint Lambrechts Woluwe, BE | Locations Lyon-3E-Arrondissement, FR HQ | Locations Woodcliff Lake, US HQ Chicago, US | Locations Wuppertal, DE HQ Borken, DE |
Employees | Employees 2630% increase | Employees 75 | Employees 10813% increase | Employees 731% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 158 m | Valuation ($) 5.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) €49.9m (FY, 2025) | Revenue (est.) €9.3m (FY, 2024) | Revenue (est.) $316.6m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods €33.5m (FY, 2025) | Cost of goods €1.1m (FY, 2024) | Cost of goods $85.5m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit €17.5m (FY, 2025) | Gross profit €11m (FY, 2024) | Gross profit $231.2m (FY, 2022) | Gross profit N/A |
Net income | Net income €1.8m (FY, 2025) | Net income (€9.3m) (FY, 2024) | Net income $35.6m (FY, 2022) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 37m | Total funding raised $ 12.3m | Total funding raised $ 74.8m |

Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins.
View company
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View companyAiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents.
View company